Technology Specialist 1/2
Monte Rosa Therapeutics
Technology Specialist 1/2
Monte Rosa Therapeutics
Develops targeted protein degraders for therapy
We are seeking a hands-on, versatile Technology Specialist — a true "jack of all trades" combining end-user computing, systems administration, and network support with a forward-looking mandate: helping our scientists and G&A teams work smarter through automation, AI-enabled tooling, and thoughtful use of our technology stack. The ideal candidate is a proactive problem-solver who takes initiative, moves fluidly between a support ticket, a patch cycle, and a workflow-automation experiment in the same day, and is genuinely excited about the potential of AI and agentic tools to reduce toil across the organization.
Automation & AI-Enabled Tooling
General IT & Help Desk Support
Compensation: 80000 to 105000 (CHF)
Develops targeted protein degraders for therapy
Monte Rosa Therapeutics develops molecular glue degraders (MGDs) to treat cancer and autoimmune/inflammatory diseases using its QuEEN discovery engine, a platform that fuses AI-guided chemistry, proteomics, and structural biology to design MGDs. MGDs work by bringing a target protein together with an E3 ligase, tagging the protein for destruction by the cell's proteasome rather than just inhibiting it. The company distinguishes itself with the QuEEN platform, partnerships with Roche and Novartis for joint development and funding, and a portfolio that includes MRT-2359, MRT-6160, and MRT-8102 as clinical-stage programs. Its goal is to discover, develop, and commercialize MGDs, grow its pipeline, and create value through collaborations, upfront payments, milestones, and royalties while delivering treatments for patients with serious diseases.
Explore more opportunities at Monte Rosa Therapeutics